NO20054798L - Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer - Google Patents
Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommerInfo
- Publication number
- NO20054798L NO20054798L NO20054798A NO20054798A NO20054798L NO 20054798 L NO20054798 L NO 20054798L NO 20054798 A NO20054798 A NO 20054798A NO 20054798 A NO20054798 A NO 20054798A NO 20054798 L NO20054798 L NO 20054798L
- Authority
- NO
- Norway
- Prior art keywords
- lifestyle
- related diseases
- foods
- preparation
- prevention
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 235000013305 food Nutrition 0.000 abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 2
- NGGYSPUAKQMTNP-UHFFFAOYSA-N Glabrene Chemical compound C1=C(O)C=C2OCC(C3=C4OC(C=CC4=C(O)C=C3)(C)C)=CC2=C1 NGGYSPUAKQMTNP-UHFFFAOYSA-N 0.000 abstract 1
- KKLOCFOZPFGVBB-UHFFFAOYSA-N Glabrene Natural products C1=C(O)C=C2OCC(C3=CC=C4OC(C=CC4=C3O)(C)C)=CC2=C1 KKLOCFOZPFGVBB-UHFFFAOYSA-N 0.000 abstract 1
- CUFAXDWQDQQKFF-DEOSSOPVSA-N Glabrol Chemical compound C1=C(O)C(CC=C(C)C)=CC([C@H]2OC3=C(CC=C(C)C)C(O)=CC=C3C(=O)C2)=C1 CUFAXDWQDQQKFF-DEOSSOPVSA-N 0.000 abstract 1
- CUFAXDWQDQQKFF-XMMPIXPASA-N Glabrol Natural products O=C1c2c(c(C/C=C(\C)/C)c(O)cc2)O[C@@H](c2cc(C/C=C(\C)/C)c(O)cc2)C1 CUFAXDWQDQQKFF-XMMPIXPASA-N 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 206010028813 Nausea Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 235000013361 beverage Nutrition 0.000 abstract 1
- 230000037396 body weight Effects 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 1
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 abstract 1
- 235000013402 health food Nutrition 0.000 abstract 1
- 210000001596 intra-abdominal fat Anatomy 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Obesity (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Edible Oils And Fats (AREA)
- Pyrane Compounds (AREA)
Abstract
Det er tilveiebrakt et preparat for å forebygge og/eller forbedre livsstilsrelaterte sykdommer som inneholder minst en forbindelse valgt fra gruppen som består av glabren, glabridin, glabrol, 3'-hydroksy- 4'-0-metylglabridin, 4'-0-metylglabridin og hyspaglabridin, som er forbindelser med en PPARy hgand aktivitet og som er effektive for å forbedre insulinresistens og for å forebygge og/eller forbedre livsstilsrelaterte sykdommer slik som visceralt fett-obesitas, type 2 diabetes, hyperlipemi og hypertensjon og som kan anvendes i næringsmidler og drikkevarer (feks. helsekost og næringsmidler med helsekrav), legemidler, kvasilegemidler eller kosmetikk, eller et preparat for å regulere og/eller forbedre kroppsvekt.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003204275 | 2003-07-31 | ||
PCT/JP2004/010381 WO2005011672A1 (ja) | 2003-07-31 | 2004-07-14 | 生活習慣病予防・改善用の油脂加工組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20054798D0 NO20054798D0 (no) | 2005-10-18 |
NO20054798L true NO20054798L (no) | 2006-01-31 |
Family
ID=34113638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054798A NO20054798L (no) | 2003-07-31 | 2005-10-18 | Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer |
Country Status (11)
Country | Link |
---|---|
US (1) | US20070098761A1 (no) |
EP (1) | EP1649854A1 (no) |
JP (1) | JPWO2005011672A1 (no) |
KR (1) | KR20060119706A (no) |
CN (1) | CN1777420A (no) |
AU (1) | AU2004261089A1 (no) |
CA (1) | CA2526589A1 (no) |
NO (1) | NO20054798L (no) |
RU (1) | RU2005126140A (no) |
TW (1) | TW200513194A (no) |
WO (1) | WO2005011672A1 (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1864643A4 (en) * | 2005-03-30 | 2011-08-17 | Kaneka Corp | PREPARATION CONTAINING OIL / FATS FOR INHIBITING THE DEVELOPMENT OF CANCER |
KR20070052211A (ko) * | 2005-11-16 | 2007-05-21 | 주식회사 엠디바이오알파 | 글라브리딘을 유효성분으로 함유하는 질환 증후군 예방 및치료용 조성물 |
WO2007060992A1 (ja) * | 2005-11-25 | 2007-05-31 | Kaneka Corporation | メタボリックシンドロームもしくはインスリン抵抗性症候群の予防または改善剤 |
TW200806306A (en) * | 2006-02-24 | 2008-02-01 | Kaneka Corp | Oil-in-water emulsion composition containing licorice-derived polyphenol |
TW200808333A (en) | 2006-04-17 | 2008-02-16 | Kaneka Corp | Licorice polyphenol preparation |
EP2163252A4 (en) * | 2007-05-17 | 2012-01-11 | Kaneka Corp | COMPOSITION CONTAINING A POLYPHENOL DERIVED FROM THE LICENSE |
US20090042813A1 (en) * | 2007-08-10 | 2009-02-12 | Sergey Michailovich Melnikov | Hoodia extract oil compositions comprising medium chain triglycerides |
WO2009025277A1 (ja) * | 2007-08-22 | 2009-02-26 | Kaneka Corporation | 還元型補酵素q10の製造方法、ならびに、その安定化方法 |
US9943560B2 (en) | 2010-02-06 | 2018-04-17 | James Zhou | Medical compositions containing liquorice extracts with synergistic effect |
JP2011231057A (ja) * | 2010-04-28 | 2011-11-17 | Kao Corp | セラミド産生促進剤 |
CN102771673A (zh) * | 2012-08-14 | 2012-11-14 | 江苏美迪森生物医药有限公司 | 一种构建代谢综合症动物模型的高脂纯化饲料及加工工艺 |
ES2964146T3 (es) * | 2016-06-29 | 2024-04-04 | Glaceum Inc | Derivado de piranocromenilfenol ópticamente activo y composición farmacéutica que lo comprende |
CN111713503A (zh) * | 2020-07-16 | 2020-09-29 | 江苏省中国科学院植物研究所 | 两种异黄酮类化合物在防治植物病害中的用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2794433B2 (ja) * | 1989-02-02 | 1998-09-03 | 丸善製薬株式会社 | 甘草疎水性フラボノイド製剤 |
JP4418550B2 (ja) * | 1999-02-17 | 2010-02-17 | 丸善製薬株式会社 | 疎水性甘草エキス含有組成物 |
TWI329516B (en) * | 2000-12-12 | 2010-09-01 | Kaneka Corp | Composition for preventing or ameliorating multiple risk factor syndromes and visceral fat-type obesity |
CN1599602A (zh) * | 2001-10-11 | 2005-03-23 | 钟渊化学工业株式会社 | 过氧化物酶体增殖剂应答性受体配体剂及其制备方法 |
WO2003074043A1 (fr) * | 2002-03-04 | 2003-09-12 | The Nisshin Oillio Group Ltd. | Agents destines a elever la temperature corporelle |
JP4191420B2 (ja) * | 2002-03-26 | 2008-12-03 | 株式会社カネカ | 甘草疎水性抽出物を含有してなる食用油脂組成物 |
-
2004
- 2004-06-28 TW TW093118894A patent/TW200513194A/zh unknown
- 2004-07-14 CA CA002526589A patent/CA2526589A1/en not_active Abandoned
- 2004-07-14 WO PCT/JP2004/010381 patent/WO2005011672A1/ja not_active Application Discontinuation
- 2004-07-14 US US10/560,900 patent/US20070098761A1/en not_active Abandoned
- 2004-07-14 KR KR1020057018163A patent/KR20060119706A/ko not_active Application Discontinuation
- 2004-07-14 AU AU2004261089A patent/AU2004261089A1/en not_active Abandoned
- 2004-07-14 JP JP2005512481A patent/JPWO2005011672A1/ja active Pending
- 2004-07-14 CN CNA2004800102175A patent/CN1777420A/zh active Pending
- 2004-07-14 EP EP04747796A patent/EP1649854A1/en not_active Withdrawn
- 2004-07-14 RU RU2005126140/15A patent/RU2005126140A/ru not_active Application Discontinuation
-
2005
- 2005-10-18 NO NO20054798A patent/NO20054798L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1649854A1 (en) | 2006-04-26 |
WO2005011672A1 (ja) | 2005-02-10 |
TW200513194A (en) | 2005-04-16 |
CN1777420A (zh) | 2006-05-24 |
RU2005126140A (ru) | 2006-02-10 |
US20070098761A1 (en) | 2007-05-03 |
AU2004261089A1 (en) | 2005-02-10 |
NO20054798D0 (no) | 2005-10-18 |
CA2526589A1 (en) | 2005-02-10 |
JPWO2005011672A1 (ja) | 2006-10-19 |
KR20060119706A (ko) | 2006-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054798L (no) | Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer | |
Reinbach et al. | Effects of capsaicin, green tea and CH-19 sweet pepper on appetite and energy intake in humans in negative and positive energy balance | |
Shidfar et al. | The effect of sumac (Rhus coriaria L.) Powder on Serum Glycemic Status, ApoB, ApoA-I and total antioxidant capacity in type 2 diabetic patients | |
JP5638180B2 (ja) | サラシア属植物の抽出物とフラボノイドを含有する食品 | |
IL215834A (en) | Composition for strengthening human liquid milk @@ hmf @@ containing @ between @@@@@ and @@@@@ from a protein of high calorie density and from @@@@@@ to @@@ kak @@ to @ m @@ to | |
NO20065748L (no) | Middel for forebygging/bedring av livstils-relaterte sykdommer som inneholder eterisk olje-komponent fra gurkemeie | |
JP2012500201A5 (no) | ||
WO2010146568A3 (en) | Bifidobacteria for treating diabetes and related conditions | |
IL172898A0 (en) | Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus | |
MY145662A (en) | Nutrition for obese patients | |
CA2517435A1 (en) | Hydroxypropylated starch for the treatment or prevention of obesity or diabetes | |
WO2008123128A1 (ja) | アディポネクチン産生促進剤 | |
Rawat et al. | Holistic approach during a pandemic for healthy well-being | |
JP2007126390A (ja) | 血糖値低下剤 | |
JP2010037319A (ja) | 内臓脂肪蓄積抑制剤 | |
KR101698201B1 (ko) | 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물을 포함하는 근육 증가 촉진, 항-피로 및 운동수행능력 향상용 조성물 | |
KR20180053032A (ko) | 신규한 피페린 유도체 및 이를 포함하는 약학적 조성물 | |
JP2007230987A (ja) | 抗肥満剤 | |
KR100406837B1 (en) | Health food composition containing natural product extract for reducing blood glucose level through the promotion of insulin release | |
TR200501978T2 (tr) | Epigallokatesin galat içeren nutrasötik kompozisyonlar | |
JP5801572B2 (ja) | PPARγ活性化剤 | |
JP2012508781A (ja) | 糖尿病の治療又は予防に使用されるピリミジニウム誘導体 | |
JP2008255048A (ja) | Ampk活性化剤 | |
JP7044342B2 (ja) | 糖尿病予防・治療用医薬組成物、血糖値改善用食品組成物、及び、糖尿病の予防・治療方法 | |
WO2020031952A1 (ja) | 血糖値上昇抑制用組成物及び血糖値上昇抑制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |